Severity: Warning
Message: getimagesize(https://technology.inquirer.net/files/2023/05/2023-05-19T220600Z_1_LYNXMPEJ4I0WK_RTROPTP_4_HEALTH-OBESITY-MARKET-470x353.jpg): Failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden
Filename: views/amp_news_detail.php
Line Number: 138
Backtrace:
File: /home/moneynations/public_html/application/views/amp_news_detail.php
Line: 138
Function: getimagesize
File: /home/moneynations/public_html/application/controllers/News.php
Line: 132
Function: view
File: /home/moneynations/public_html/index.php
Line: 291
Function: require_once
DUBLIN — Taking Novo Nordisk’s new obesity drug may help reduce the risk of heart disease as well as boost weight loss, according to new research from the United States. After a year of taking semaglutide, marketed as Wegovy, patients’ risk of suffering from conditions like a heart attack or a stroke over the next […]
The post Obesity drug brings heart health benefit alongside weight loss – study appeared first on Inquirer Technology.
Read more at: inquirerDisclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Bollywood charcha does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.